- Home
- SABA vs HRTX Comparison
SABA vs HRTX Comparison
Compare SABA & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABA
- HRTX
- Stock Information
- Founded
- SABA 1988
- HRTX 1983
- Country
- SABA United States
- HRTX United States
- Employees
- SABA N/A
- HRTX N/A
- Industry
- SABA
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- SABA
- HRTX Health Care
- Exchange
- SABA Nasdaq
- HRTX Nasdaq
- Market Cap
- SABA 252.3M
- HRTX 242.0M
- IPO Year
- SABA N/A
- HRTX 1987
- Fundamental
- Price
- SABA $8.77
- HRTX $1.20
- Analyst Decision
- SABA
- HRTX Strong Buy
- Analyst Count
- SABA 0
- HRTX 2
- Target Price
- SABA N/A
- HRTX $4.50
- AVG Volume (30 Days)
- SABA 290.0K
- HRTX 1.5M
- Earning Date
- SABA 01-01-0001
- HRTX 11-04-2025
- Dividend Yield
- SABA 12.91%
- HRTX N/A
- EPS Growth
- SABA N/A
- HRTX N/A
- EPS
- SABA N/A
- HRTX N/A
- Revenue
- SABA N/A
- HRTX $149,694,000.00
- Revenue This Year
- SABA N/A
- HRTX $10.62
- Revenue Next Year
- SABA N/A
- HRTX $12.99
- P/E Ratio
- SABA N/A
- HRTX N/A
- Revenue Growth
- SABA N/A
- HRTX 9.78
- 52 Week Low
- SABA $3.64
- HRTX $1.04
- 52 Week High
- SABA $4.42
- HRTX $2.68
- Technical
- Relative Strength Index (RSI)
- SABA 32.06
- HRTX 38.46
- Support Level
- SABA $8.78
- HRTX $1.28
- Resistance Level
- SABA $9.00
- HRTX $1.38
- Average True Range (ATR)
- SABA 0.12
- HRTX 0.07
- MACD
- SABA -0.02
- HRTX 0.00
- Stochastic Oscillator
- SABA 12.34
- HRTX 7.32
About SABA Saba Capital Income & Opportunities Fund II Shares of Beneficial Interest
Saba Capital Income & Opportunities Fund II is a closed-end fund. The company seeks high current income, with a secondary goal of capital appreciation. The fund invests in fixed income markets across the globe.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.